Pharmaceutical Companies Cutting Ties With Russia

  • 📰 WebMD
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Major pharmaceutical companies are ending or reducing their business relationships with Russia in response to the war in Ukraine, though most companies say they’ll keep sending essential drugs for humanitarian reasons.

U.S.-based Pfizer, maker of the COVID-19 vaccine with its European partner BioNTech, doesn’t own any manufacturing plants in Russia but says it will stop planned investments and all clinical trials there, though it will keep supplying drugs to already enrolled patients.

Eli Lilly says it will also stop sending non-essential medicines to Russia, including the erectile dysfunction drug Cialis,Bayer will stop all spending in Russia and Belarus that’s not related to supplying essential products for health and agriculture, the company said in a. The company will suspend all advertising and promotions, halt capital investment projects, and not pursue any business opportunities.

Bristol Myers Squibb will suspend clinical trials in Ukraine, Belarus, and Russia, Endpoints said. The company has about 160 employees in Russia but no manufacturing facilities.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

❤️

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 709. in RU

Россия Последние новости, Россия Последние новости